Table 1.
Baseline characteristics
| REACT n = 180 | ENRICH n = 64 | MM4L n = 330 | Pooled n = 574 | |
|---|---|---|---|---|
| Physical activity | ||||
| Mean daily activity counts, mean (SD) | 252.3 (97.8) | }z-score | ||
| Mean daily steps, mean (SD) | 8406.2 (3485.5) | 7694.8 (2831.6) | ||
| Demographic | ||||
| Age, mean (SD) (years) | 51.8 (9.4) | 54.8 (11.0) | 55.9 (8.3) | 54.5 (9.2) |
| Married or de facto (n(%)) | 148 (82) | 41 (64) | 250 (77) | 439 (77) |
| Education | ||||
| Low/intermediate (n(%)) | 106 (60) | 34 (54) | 184 (56) | 324 (57) |
| High (n(%)) | 72 (40) | 29 (46) | 146 (44) | 247 (43) |
| Being employed, | ||||
| Employed, (n(%)) | 121 (67) | 32 (51) | 189 (57) | 342 (60) |
| Not employed, (n(%)) | 59 (33) | 31 (49) | 141 (43) | 231 (40) |
| Clinical | ||||
| Type of treatment, | ||||
| Chemotherapy (yes) (n(%)) | 180 (100) | 52 (85) | 231 (70) | 463 (81) |
| Radiation therapy (yes) (n(%)) | 124 (69) | 49 (85) | 225 (68) | 398 (70) |
| Surgery (yes) (n(%)) | 177 (98) | 62 (97) | 306 (93) | 545 (95) |
| Immunotherapy (yes) (n(%)) | 35 (19) | 0 | 15 (5) | 50 (9) |
| Hormone therapy (yes) (n(%)) | 125 (69) | 45 (82) | 201 (61) | 371 (66) |
| Time between date of diagnosis and baseline, mean (SD) (months) | 7.9 (1.5) | 44.2 (83.5) | 69.0 (50.9) | 47.6 (55.1) |
| History of cancer (yes) (n(%)) | 15 (8) | 4 (7) | 19 (6) | 38 (7) |
| Sum of comorbidities, mean (SD) | 0.5 (0.7) | 2.3 (1.7) | 1.7 (1.5) | 1.4 (1.5) |
| BMI (kg/m2), mean (SD) | 27.2 (4.8) | 27.0 (6.1) | 26.9 (5.2) | 27.0 (5.2) |
| Psychosocial (Range 0–100) | ||||
| Self-efficacy, mean (SD) | 60.0 (16.7) | 52.5 (17.8) | 50.7 (22.3) | z-score |
| Social support, mean (SD) | 80.3 (20.4) | 48.8 (33.2) | 30.1 (15.6) | z-score |
| Outcome expectations, mean (SD) | 76.4 (14.7) | 73.4 (16.6) | 81.8 (13.9) | 79.2 (14.8) |
| Environmental | ||||
| Urban area, (yes) (n(%)) | 45 (25) | 64 (100) | 155 (47) | 264 (46) |
SD standard deviation, n number